Literature DB >> 2319115

Total digoxin-like immunoreactive factor(s) in healthy population, uncomplicated term pregnancies and neonates.

N Krivoy1, P Jakobi, E Paldi, G Alroy.   

Abstract

Free digoxin-like immunoreactive factor(s) (DLIF) which may have a homeostatic role, as documented in different physiological conditions, but is generally undetectable in plasma from normal population. Total digoxin-like immunoreactive factor(s) (protein bound and free) can be estimated after plasma is heated. In this study, total digoxin-like immunoreactive factor(s) as measured in plasma in a well defined control population and compared to healthy term pregnant women and neonates, categories known to be associated with increased free digoxin-like immunoreactive factor(s) concentrations. The mean level of this factor(s) in the control group was 706 +/- 129 pg digoxin equivalent/ml (pg/ml) and was unaffected by age and sex. Significantly increased levels of total digoxin-like immunoreactive factor(s) were found in pregnant women and neonates (928 +/- 127 and 1242 +/- 367 pg/ml, respectively). We conclude that levels of total digoxin-like immunoreactive factor(s) are increased in term pregnancies and neonates, similarly to its free form. However total digoxin-like immunoreactive factor(s) is detected in the normal population as a plasma component, contrary to its free form, which is generally undetectable.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2319115     DOI: 10.1007/BF03348569

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Endogenous digoxin-like immunoreactivity in congestive heart failure.

Authors:  L Shilo; A Adawi; G Solomon; L Shenkman
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-15

2.  Endogenous digoxin-like material is of adrenal origin.

Authors:  L Shilo; M S Shapiro; S Dolev; L Shenkman
Journal:  Isr J Med Sci       Date:  1987-04

3.  Endogenous digoxin-like immunoreactivity in blood is increased during prolonged strenuous exercise.

Authors:  R Valdes; J M Hagberg; T E Vaughan; B W Lau; D R Seals; A A Ehsani
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

4.  The influence of gestational age and preeclampsia on the presence and magnitude of serum endogenous digoxin-like immunoreactive substance(s).

Authors:  S J Phelps; E B Cochran; A Gonzalez-Ruiz; E A Tolley; K D Hammond; B M Sibai
Journal:  Am J Obstet Gynecol       Date:  1988-01       Impact factor: 8.661

5.  Correlations between digoxin-like immunoreactivity and electrolyte values in urinary samples of newborns.

Authors:  A Clerico; A Boldrini; M G Del Chicca; P Biver; M Fantoni; L Mezzasalma; C Fassorra; C Cipolloni
Journal:  Biol Neonate       Date:  1986

6.  Digoxin-like immunoreactivity: occurrence in three molecular forms and partial characterization.

Authors:  L Shilo; M M Werber; S Dolev; M Shapiro; L Shenkman
Journal:  J Clin Endocrinol Metab       Date:  1987-06       Impact factor: 5.958

7.  Digoxin-like immunoreactive substance in patients with aneurysmal subarachnoid haemorrhage.

Authors:  E F Wijdicks; M Vermeulen; P van Brummelen; N C den Boer; J van Gijn
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-21

Review 8.  Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications.

Authors:  R Valdes
Journal:  Clin Chem       Date:  1985-09       Impact factor: 8.327

9.  Evidence for a circulating endogenous Na+-K+ pump inhibitor in low-renin hypertension.

Authors:  F J Haddy; M B Pamnani
Journal:  Fed Proc       Date:  1985-09

10.  Protein binding of endogenous digoxin-immunoactive factors in human serum and its variation with clinical condition.

Authors:  R Valdes; S W Graves
Journal:  J Clin Endocrinol Metab       Date:  1985-06       Impact factor: 5.958

View more
  1 in total

Review 1.  The endogenous digitalis-like factor.

Authors:  F Kölbel; V Schreiber
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.